Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492060 · ClinicalTrials.gov registry record
Longitudinal Study of Neurogenetic Disorders
A clinical trial of Autism Spectrum Disorder and Seizures, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03492060 is a study of Autism Spectrum Disorder and Seizures that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants, above the 131-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (663% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03492060, a study of Autism Spectrum Disorder and Seizures, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze patterns in individuals with hnRNP (and other) genetic variants, including their neurological comorbidities, other medical problems and any treatment. The investigators will maintain an ongoing database of medical data that is otherwise being collected for routine medical care. The investigators will also collect data prospectively in the form of questionnaires, neuropsychological assessments, motor assessments, and electroencephalography to examine the landscape of deleterious variants in these genes.
Conditions Studied
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03492060
The ClinicalTrials.gov registry entry for NCT03492060 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 131-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (663% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT03492060 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03492060 about?
NCT03492060 is a clinical study titled "Longitudinal Study of Neurogenetic Disorders". The purpose of this study is to analyze patterns in individuals with hnRNP (and other) genetic variants, including their neurological comorbidities, other medical problems and any treatment. The investigators will maintain an ongoing database of medical data that is otherwise being collected for rou...
What is the current status of trial NCT03492060?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2018-06-13. Estimated completion is 2030-12.
What conditions does trial NCT03492060 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Seizures, Neurodevelopmental Disorders, Intellectual Disability, Developmental Delay.
Who is sponsoring clinical trial NCT03492060?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03492060 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.